Quantitative Decision Making
Supporting the drug development pathway through high quality reproducible quantitative analyses.
Our Approach
We pride ourselves on delivering high-quality, innovative, and pragmatic solutions that empower strategic decision-making during drug development. By working closely with each client, we gain a thorough understanding of their unique needs and deliver on time and on budget solutions tailored to their specific requirements. Using regulatory-accepted, industry-standard modeling software, we ensure each project meets the highest standards in drug development.
Our Services
We are involved in all aspects of quantitative analysis and strategic decision making during drug development. Collectively we have contributed to projects spanning from pre-clinical to Phase III filings, working closely with regulatory agencies like the FDA, EMA, and others. Our services include population pharmacokinetic / pharmacodynamic modeling and simulation, exposure-response analyses, clinical trial design and simulation, and more.
Our Consultants
Our consultants are composed of industry experts with deep knowledge of quantitative analysis required during drug development. With diverse backgrounds and extensive experience, we bring a wealth of insights to every project. Dedicated to innovation and excellence, our consultants work closely with clients, combining technical expertise with a commitment to high-quality, tailored solutions.